XOM News Alert Exxon Mobil Corp (XOM) 92.83 01/03/2015 14:35

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Exxon Mobil Corp (XOM) 92.83 $XOM

Investing Versus Speculating In My DGI Portfolio
DGI Guy - at Seeking Alpha - Sat Jan 03, 5:50AM CST

MKC: 73.95 (-0.35), GPC: 106.52 (-0.05), UTX: 115.04 (+0.04), KMB: 115.55 (+0.01), XOM: 92.83 (+0.38), WMT: 85.90 (+0.02), WEC: 53.19 (+0.45), PEP: 94.44 (-0.12), JNJ: 104.52 (-0.05), T: 33.87 (+0.28), CINF: 51.61 (-0.22), PAYX: 46.24 (+0.07), TGT: 75.33 (-0.58), CAT: 91.88 (+0.35), MSFT: 46.76 (+0.31), KO: 42.14 (-0.08), CHD: 79.09 (+0.28), EMR: 61.79 (+0.06), UL: 39.98 (-0.50), TUP: 62.40 (-0.60), BAX: 73.31 (+0.02), MCD: 93.26 (-0.44), PG: 90.44 (-0.65), GIS: 53.11 (-0.22), VZ: 46.96 (+0.18), CL: 69.04 (-0.15)

Final Glance: Oil companies
AP - Fri Jan 02, 5:52PM CST
NEW YORK (AP) — Shares of some top oil companies were mixed at the close of trading:
XOM: 92.83 (+0.38), BP: 38.12 (unch), MRO: 28.60 (+0.31)

Exxon Mobil (XOM) Stock Erases Gains in After-Hours Trading Today
at The Street - Fri Jan 02, 3:54PM CST
Exxon Mobil (XOM) shares are down in after-hours trading as falling oil prices continue to hurt the sector.
XOM: 92.83 (+0.38)

Want to Know What Happens to Oil in 2015? Watch These 3 Key Things
Tyler Crowe and Mark Reeth, The Motley Fool - Motley Fool - Fri Jan 02, 2:02PM CST
For many energy investors, 2015 probably couldn't come soon enough considering the miserable performance that the industry posted in 2014. Then again, its very possible that 2015 might not be that great either. There is no way that anyone can predict...
KMI: 42.81 (+0.50), XOM: 92.83 (+0.38), HFC: 38.44 (+0.96)

Weak oil prices may spark European oil and gas deal-making
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 1:55PM CST

RDS.B: 69.12 (-0.44), RDS.A: 66.98 (+0.03), XOM: 92.83 (+0.38), BP: 38.12 (unch)

Interest Rates Will Be Just One of the Themes to Watch in 2015
at The Street - Fri Jan 02, 1:53PM CST
The CNBC 'Fast Money Halftime' trading panel look at rising interest rates, technology stocks and increased volatility as some of the big themes to watch in 2015.
KO: 42.14 (-0.08), MNST: 108.16 (-0.19), VXX: 30.99 (-0.52), GMCR: 131.97 (-0.43), XOM: 92.83 (+0.38), DIS: 93.75 (-0.44), TLT: 127.32 (+1.40), SPY: 205.43 (-0.11), QQQ: 102.94 (-0.31), DIA: 177.94 (+0.06), JCP: 6.29 (-0.19), APA: 63.83 (+1.16), MCD: 93.26 (-0.44), IWM: 118.93 (-0.69), XLF: 24.73 (unch), CVX: 112.58 (+0.40)

Midday Glance: Oil companies
AP - Fri Jan 02, 12:20PM CST
NEW YORK (AP) — Shares of some top oil companies are mixed at 1 p.m.:
XOM: 92.83 (+0.38), BP: 38.12 (unch), MRO: 28.60 (+0.31)

Exxon seeks to bar release of files on abandoned pipeline
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 11:56AM CST

XOM: 92.83 (+0.38)

Early Glance: Oil companies
AP - Fri Jan 02, 9:21AM CST
NEW YORK (AP) — Shares of some top oil companies are down at 10 a.m.:
XOM: 92.83 (+0.38), BP: 38.12 (unch), MRO: 28.60 (+0.31)

Stock Market News for January 02, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 9:10AM CST
Markets ended in the red zone on the last trading day of 2014 as disappointing economic data dented investor sentiment
D: 77.49 (+0.59), DHI: 24.96 (-0.33), LEN: 44.29 (-0.52), AES: 13.70 (-0.07), EXC: 37.57 (+0.49), DUK: 84.05 (+0.51), CHK: 19.76 (+0.19), PHM: 21.26 (-0.20), XOM: 92.83 (+0.38), CVX: 112.58 (+0.40), SO: 49.37 (+0.26), TOL: 34.23 (-0.04), SLB: 85.67 (+0.26)

Oil Might Be Down, But It’s Certainly Not Out
Matt DiLallo, The Motley Fool - Motley Fool - Fri Jan 02, 8:16AM CST
Without a doubt 2014 will go down as a rough year for the oil industry. Crude oil prices plunged about 50% on the year as surging supplies were met with tepid demand. That being said, while demand for oil wasn't as robust as some expected, that...
XOM: 92.83 (+0.38)

Why Saudi Arabia Doesn't Care If Oil Hits $20
Short/Long Trader - at Seeking Alpha - Fri Jan 02, 7:21AM CST

CLR: 38.79 (+0.43), OIL: 12.21 (-0.33), EOG: 92.24 (+0.17), XOM: 92.83 (+0.38), COP: 68.92 (-0.14), SLCA: 26.51 (+0.82)

Overcome the Crude Carnage with These Picks - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 12:00AM CST
Overcome the Crude Carnage with These Picks - Industry Outlook
VLO: 50.34 (+0.84), RDS.A: 66.98 (+0.03), TOT: 51.16 (-0.04), TSO: 75.50 (+1.15), APL: 28.04 (+0.78), SEP: 56.03 (-0.94), XOM: 92.83 (+0.38), WNR: 38.36 (+0.58), CVX: 112.58 (+0.40), MUSA: 67.84 (-1.02), MMP: 84.72 (+2.06)

ConocoPhillips, A Leader In The S&P 500 Energy Sector
Julie Young - at Seeking Alpha - Thu Jan 01, 1:44PM CST

COP: 68.92 (-0.14), XOM: 92.83 (+0.38), CVX: 112.58 (+0.40)

12 Of The Safest Dividend Aristocrats
Dividend Yield - at Seeking Alpha - Thu Jan 01, 5:18AM CST
Happy New Year! It was a fantastic year 2014 and I hope you've also generated a good performance. I hope that this year can also produce a solid return for my portfolio despite the fact that many analysts are scared about the current market...
SWK: 96.02 (-0.06), MMM: 164.06 (-0.26), JNJ: 104.52 (-0.05), ADP: 83.29 (-0.08), GPC: 106.52 (-0.05), TROW: 85.76 (-0.10), EMR: 61.79 (+0.06), XOM: 92.83 (+0.38), DOV: 71.98 (+0.26), CVX: 112.58 (+0.40), ITW: 94.68 (-0.02), AFL: 61.08 (-0.01)

2014 leaders and laggards
Seeking Alpha - at Seeking Alpha - Thu Jan 01, 1:19AM CST

VIP: 4.28 (+0.10), GE: 25.06 (-0.21), EA: 46.87 (-0.14), GMCR: 131.97 (-0.43), UNH: 100.78 (-0.31), WYNN: 146.89 (-1.87), ILMN: 185.42 (+0.84), XOM: 92.83 (+0.38), INTC: 36.36 (+0.07), LUV: 42.69 (+0.37), AGN: 212.75 (+0.16), RIG: 18.12 (-0.21), MAT: 30.47 (-0.47), IBM: 162.06 (+1.62), AAL: 53.91 (+0.28), DNR: 7.92 (-0.21), MSFT: 46.76 (+0.31), CSCO: 27.61 (-0.21), AMZN: 308.52 (-1.83), HD: 103.43 (-1.54), AVP: 9.31 (-0.08), EW: 127.72 (+0.34), DISCA: 34.48 (+0.03), ESV: 30.17 (+0.22), CVX: 112.58 (+0.40), VZ: 46.96 (+0.18), AVGO: 100.09 (-0.50), NE: 16.84 (+0.27)

American Eagle Energy Halts Drilling On Cheap Oil
at Investor's Business Daily - Wed Dec 31, 12:42PM CST
American Eagle Energy (AMZG) said Wednesday that it has stopped drilling operations and was unlikely to restart them until oil prices picked back up, sending shares down by more than 20% in the stock market today to their lowest level since 2009....
XOM: 92.83 (+0.38), AMZG: 0.77 (+0.15)

A Giant Gas Well Confirms Deep Utica Potential
Richard Zeits - at Seeking Alpha - Wed Dec 31, 11:45AM CST

NBL: 46.88 (-0.55), EQT: 77.52 (+1.82), RDS.B: 69.12 (-0.44), CNX: 34.30 (+0.49), RICE: 22.02 (+1.05), RDS.A: 66.98 (+0.03), CHK: 19.76 (+0.19), XOM: 92.83 (+0.38), CVX: 112.58 (+0.40), RRC: 55.40 (+1.95), SWN: 27.17 (-0.12)

Stocks Bounce Back; Airlines Lead As Oil Falls
at Investor's Business Daily - Wed Dec 31, 10:58AM CST
Stocks bounced back Wednesday and looked to wrap up 2014 on a positive note. The Nasdaq was up 0.4% while the S&P 500 added 0.1% and the Dow Jones industrial average climbed 0.2%. As expected, volume is tracking lighter across the board ahead of the...
DDS: 121.79 (-3.39), HD: 103.43 (-1.54), RJET: 14.46 (-0.13), XOM: 92.83 (+0.38), JWN: 78.37 (-1.02), M: 65.69 (-0.06), CVX: 112.58 (+0.40), MANH: 39.72 (-1.00)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 1

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 4

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 6

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading

Top 5 Most Recently Viewed Articles

Cingulate Inc. Shows Progress with Q2 2025 Financial Results

Updated Category News Views 142

Cingulate Inc. Announced Financial Highlights for Q2 2025 Cingulate Inc. (NASDAQ: CING), a prominent biopharmaceutical company focused on innovative ADHD treatments, recently disclosed its financial results for the second quarter of 2025, alongside significant advancements. Central to the company’s activities was the submission of the New Drug Application (NDA) for its...

Continue Reading
Discover How Your Investment in Carvana Could Have Grown

Updated Category News Views 127

Investment Growth Over Five Years Investing wisely can create remarkable returns over time. A case in point is Carvana Co (NASDAQ: CVNA), which has significantly outperformed expectations in recent years. Over the past five years, Carvana has shown an impressive annualized return of 18.46%, surpassing the market by 4.39% each year. Presently, Carvana's market...

Continue Reading
Deko Cocktails Triumphs with Best New RTD Award Success

Updated Category News Views 92

Deko Cocktails Achieves WSWA Best RTD Award Deko Cocktails, a newly launched line of expertly crafted ready-to-serve cocktails, recently secured a prestigious accolade in the beverage alcohol industry. The company was honored with the Best RTD (Ready to Drink) Product of the Year at the Wine & Spirit Wholesalers of America (WSWA) Brand Battle. This annual competition...

Continue Reading
Bouygues SA Shares and Voting Rights Update for January 2025

Updated Category News Views 205

Key Insights on Bouygues SA's Monthly Share and Voting Rights Bouygues SA regularly updates its shareholders about essential metrics, including the total number of shares and the voting rights attached to them. Understanding these details is vital for investors and stakeholders who wish to stay informed of the company's standing in the market. Transparency in Shareholder...

Continue Reading
Challenges Faced by Oncternal Therapeutics and Stock Update

Updated Category News Views 94

Oncternal Therapeutics Inc. (ONCT) was in dire straits back then, hitting a notable low of $1.31 amidst a turbulent market that left investors biting their nails. This stock plunge represented a hefty drop of -76.33%, rattling traders who were already on edge over the biopharmaceutical company’s struggle to bring innovative cancer therapies to market. The company's...

Continue Reading